サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1713327

インフルエンザ診断薬の世界市場レポート 2025年

Influenza Diagnostic Global Market Report 2025

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
インフルエンザ診断薬の世界市場レポート 2025年
出版日: 2025年04月09日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

インフルエンザ診断薬市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.5％で40億1,000万米ドルに成長します。予測期間の成長は、カスタマイズと拡張性、環境と持続可能性の目標、業務効率改善の必要性、現代のサプライチェーンダイナミクスの要求に応える必要性などに起因すると考えられます。予測期間の主な動向には、先進技術の統合、ロボットによるピッキングと梱包、自律移動ロボット、リアルタイムデータと分析、AIによる意思決定、協働ロボット、ロボット技術の進歩などが含まれます。

迅速診断検査はインフルエンザ診断薬市場の成長を牽引すると予想されます。これらの検査は、状態や疾患を迅速に確認または除外するために設計された医療ツールであり、ヘルスケアにおける正確かつタイムリーな結果に対する需要の高まりに対応しています。迅速インフルエンザ診断薬検査（RIDT）は、10～15分以内にインフルエンザウイルス抗原を検出し、中程度の感度（50～70％）を提供する能力で特に評価されています。例えば、2024年7月、オーストラリア保健福祉研究所は、画像診断サービスが2021-22年の2,840万件から2022-23年には2,970万件に増加したと報告しました。その結果、迅速診断検査の普及がインフルエンザ診断薬市場を後押ししています。

インフルエンザ診断に関する調査への資金提供の増加は、市場成長を促進する重要な要因です。インフルエンザが公衆衛生に与える影響を理解するには、ウイルスとその個人および集団への影響に関する包括的な調査が必要です。公衆衛生に重大な影響を与える科学の進歩を加速させることは不可欠です。官民の保健機関、研究者、ヘルスケア専門家、バイオ製薬会社は、パンデミックインフルエンザのリスクを軽減するために、研究資金や助成金への投資を増やしています。例えば、オーストラリア政府は2024年10月、保健・高齢者介護省を通じて、農業、野生生物、経済の保護を目的として、鳥インフルエンザ対策に9,500万米ドルを割り当てた。その結果、研究資金の増加がインフルエンザ診断薬市場を後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界インフルエンザ診断薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
  • 最終用途産業の分析
  • 世界のインフルエンザ診断薬市場：成長率分析
  • 世界のインフルエンザ診断薬市場の実績：規模と成長, 2019-2024
  • 世界のインフルエンザ診断薬市場の予測：規模と成長, 2024-2029, 2034F
  • 世界インフルエンザ診断薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界のインフルエンザ診断薬市場従来の診断テストによる、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 迅速インフルエンザ診断薬テスト（RIDT）
  • ウイルス培養
  • DFA
  • 血清学的検査
  • その他の従来の診断検査
  • 世界のインフルエンザ診断薬市場分子診断検査による、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 逆転写ポリメラーゼ連鎖反応（RT-PCR）
  • 等温核酸増幅検査（INAAT）
  • ループ媒介等温増幅アッセイ
  • 転写を介した等温増幅アッセイ
  • 転写を介した等温増幅アッセイ
  • その他の等温核酸増幅検査
  • その他の分子診断検査
  • 世界のインフルエンザ診断薬市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院と臨床検査室
  • 診断リファレンスラボ
  • 学術調査機関
  • その他のエンドユーザー
  • 世界のインフルエンザ診断薬市場、迅速インフルエンザ診断薬テスト（RIDT）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 免疫測定法に基づく検査
  • ラテラルフローアッセイ
  • 酵素免疫測定（EIA）
  • 世界のインフルエンザ診断薬市場ウイルス培養の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 細胞培養
  • 卵ベースの培養
  • 世界のインフルエンザ診断薬市場直接蛍光抗体（DFA）検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 直接蛍光抗体染色
  • 世界のインフルエンザ診断薬市場血清学的検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 血球凝集抑制（HI）アッセイ
  • 酵素免疫測定（ELISA）
  • ウェスタンブロッティングアッセイ
  • 世界のインフルエンザ診断薬市場、他の従来の診断テストの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ポリメラーゼ連鎖反応（PCR）
  • 免疫蛍光アッセイ

第7章 地域別・国別分析

  • 世界のインフルエンザ診断薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界のインフルエンザ診断薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • インフルエンザ診断薬市場：競合情勢
  • インフルエンザ診断薬市場：企業プロファイル
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Becton Dickinson and Company
  • DiaSorin SpA
  • Luminex Corporation
  • Meridian Bioscience Inc.
  • GenMark Diagnostics Inc.
  • SA Scientific Ltd.
  • Sekisui Diagnostics LLC
  • bioMerieux Inc.
  • Danaher Corporation
  • Siemens Healthineers AG
  • Coris Bioconcept Sprl
  • Mast Group
  • Elitech Technology Inc.
  • Analytik Jena AG
  • altona Diagnostics GmbH

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • インフルエンザ診断薬市場2029：新たな機会を提供する国
  • インフルエンザ診断薬市場2029：新たな機会を提供するセグメント
  • インフルエンザ診断薬市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r32605

The diagnosis of influenza, commonly known as the flu, involves employing various tests to detect the presence of the influenza virus. These diagnostic methods include viral culture, serology, rapid antigen testing, reverse transcription-polymerase chain reaction (RT-PCR), immunofluorescence assays, and rapid molecular assays. Influenza is caused by three primary types of the influenza virus such as type A, type B, and type C. Its symptoms typically include fever, sore throat, cough, body ache, fatigue, and headache. The market for influenza diagnostics encompasses the revenues generated by entities involved in conducting tests for the detection of the influenza virus.

The conventional diagnostic tests for influenza comprise rapid influenza diagnostic tests (RIDT), viral culture, DFA, serological assays, and other tests. Rapid influenza diagnostic tests (RIDTs) are immunoassays capable of identifying the presence of influenza A and B viral nucleoprotein antigens in respiratory samples, offering a qualitative outcome (positive or negative). Molecular diagnostic tests encompass a range of methods such as Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), loop-mediated isothermal-based amplification assays, transcription-mediated isothermal-based amplification assays, and other isothermal nucleic acid amplification tests. These tests are employed by hospitals, clinical laboratories, diagnostic reference laboratories, academic/research institutes, and other end users.

The influenza diagnostic market research report is one of a series of new reports from The Business Research Company that provides influenza diagnostic market statistics, including influenza diagnostic industry global market size, regional shares, competitors with a influenza diagnostic market share, detailed influenza diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the influenza diagnostic industry. This influenza diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The influenza diagnostic market size has grown strongly in recent years. It will grow from $2.73 billion in 2024 to $2.89 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to e-commerce growth, labor shortages, automation and productivity, supply chain optimization, rising costs of labor, government support for automation and robotics.

The influenza diagnostic market size is expected to see strong growth in the next few years. It will grow to $4.01 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to customization and scalability, environmental and sustainability goals, need to improve operational efficiency, need to meet the demands of modern supply chain dynamics. Major trends in the forecast period include advanced technology integration, robotic picking and packing, autonomous mobile robots, real-time data and analytics, ai-driven decision making, collaborative robots, advancements in robotic technology.

Rapid diagnostic tests are anticipated to drive the growth of the influenza diagnostic market. These tests are medical tools designed to quickly confirm or rule out a condition or disease, addressing the rising demand for accurate and timely results in healthcare. Rapid influenza diagnostic tests (RIDTs) are particularly valued for their ability to detect influenza viral antigens within 10-15 minutes, offering moderate sensitivity (50-70%). For example, in July 2024, the Australian Institute of Health and Welfare reported that diagnostic imaging services increased from 28.4 million in 2021-22 to 29.7 million in 2022-23. Consequently, the growing adoption of rapid diagnostic tests is propelling the influenza diagnostic market.

Increasing funding for research on influenza diagnostics is a key factor driving market growth. Understanding the public health impact of influenza requires comprehensive research into the virus and its effects on individuals and populations. Accelerating scientific advancements with significant public health implications is essential. Public and private health organizations, researchers, healthcare professionals, and biopharmaceutical companies have been increasing investments in research funding or grants to mitigate the risks of pandemic influenza. For example, in October 2024, the Australian Government, through the Department of Health and Aged Care, allocated $95 million to combat avian influenza, aimed at protecting agriculture, wildlife, and the economy. As a result, increasing research funding is propelling the influenza diagnostic market.

Key players in the influenza diagnostic market are actively innovating and developing groundbreaking products like the Lucira COVID-19 & Flu Home Test, allowing rapid simultaneous qualitative detection. This single-use at-home test kit enables users to obtain results from self-collected nasal swab samples in approximately 30 minutes. An example of such innovation is the approval received by Pfizer Inc., a US-based pharmaceutical company, in February 2023 for the Lucira by Pfizer COVID-19 & Flu Home Test. This test is capable of detecting both influenza A and B (commonly known as the flu) and SARS-CoV-2, the virus responsible for COVID-19.

The utilization of rapid influenza diagnostic tests (RIDTs) in influenza diagnostics is increasingly prevalent. RIDTs, which are immunoassays, identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, providing a qualitative result (positive or negative). These tests deliver outcomes within a clinically relevant timeframe of approximately 15 minutes and are particularly effective in diagnosing patients with influenza-like symptoms, especially within the first four days of symptom onset. The growing favor for RIDTs is attributed to their user-friendly nature and swift diagnostic capabilities.

In February 2024, Thyrocare Technologies Limited, an India-based healthcare company, acquired Think Health Diagnostic Private Limited for an undisclosed amount. The acquisition expands Thyrocare's service portfolio, enabling broader customer outreach and strengthening its market share in the diagnostic sector. This integration also introduces at-home ECG testing alongside blood diagnostics, establishing Thyrocare as a comprehensive provider for premedical and annual health checkups. Think Health Diagnostic Private Limited is an India-based home healthcare services company specializing in telehealth, laboratory testing, and pharmacy services.

Major companies operating in the influenza diagnostic market include F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMerieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc., TotalWellness Ltd., Health Advocate Inc., Optum Global Solutions Private Ltd.

North America was the largest region in the influenza diagnostics market in 2024. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the influenza diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The influenza diagnostic market includes revenue earned by test kit and reagents, and other products. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Influenza Diagnostic Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on influenza diagnostic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for influenza diagnostic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The influenza diagnostic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT); Viral Culture; DFA; Serological assays; Other Traditional diagnostic tests
  • 2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR); Isothermal Nucleic Acid Amplification Tests (INAAT); Loop Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Other Isothermal Nucleic Acid Amplification Tests; Other Molecular Diagnostic Tests
  • 3) By End User: Hospitals And Clinical Laboratories; Diagnostic Reference Laboratories; Academic/Research Institutes; Other End Users
  • Subsegments:
  • 1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests; Lateral Flow Assays; Enzyme Immunoassays (EIA)
  • 2) By Viral Culture: Cell Culture; Egg-based Culture
  • 3) By Direct Fluorescent Antibody (DFA) Test: Direct Fluorescent Antibody Staining
  • 4) By Serological Assays: Hemagglutination Inhibition (HI) Assay; Enzyme-Linked Immunosorbent Assay (ELISA); Western Blotting Assay
  • 5) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR); Immunofluorescence Assays
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Quidel Corporation; Thermo Fisher Scientific Inc.; Abbott Laboratories; Hologic Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Influenza Diagnostic Market Characteristics

3. Influenza Diagnostic Market Trends And Strategies

4. Influenza Diagnostic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Influenza Diagnostic Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Influenza Diagnostic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Influenza Diagnostic Market Growth Rate Analysis
  • 5.4. Global Influenza Diagnostic Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Influenza Diagnostic Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Influenza Diagnostic Total Addressable Market (TAM)

6. Influenza Diagnostic Market Segmentation

  • 6.1. Global Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rapid Influenza Diagnostic Tests (RIDT)
  • Viral Culture
  • DFA
  • Serological Assays
  • Other Traditional Diagnostic Tests
  • 6.2. Global Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reverse Transcription Polymerase Chain Reaction (RT-PCR)
  • Isothermal Nucleic Acid Amplification Tests (INAAT)
  • Loop Mediated Isothermal Based Amplification Assays
  • Transcription Mediated Isothermal Based Amplification Assays
  • Transcription Mediated Isothermal Based Amplification Assays
  • Other Isothermal Nucleic Acid Amplification Tests
  • Other Molecular Diagnostic Tests
  • 6.3. Global Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinical Laboratories
  • Diagnostic Reference Laboratories
  • Academic/Research Institutes
  • Other End Users
  • 6.4. Global Influenza Diagnostic Market, Sub-Segmentation Of Rapid Influenza Diagnostic Tests (RIDT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immunoassay-based Tests
  • Lateral Flow Assays
  • Enzyme Immunoassays (EIA)
  • 6.5. Global Influenza Diagnostic Market, Sub-Segmentation Of Viral Culture, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell Culture
  • Egg-based Culture
  • 6.6. Global Influenza Diagnostic Market, Sub-Segmentation Of Direct Fluorescent Antibody (DFA) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Fluorescent Antibody Staining
  • 6.7. Global Influenza Diagnostic Market, Sub-Segmentation Of Serological Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hemagglutination Inhibition (HI) Assay
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Western Blotting Assay
  • 6.8. Global Influenza Diagnostic Market, Sub-Segmentation Of Other Traditional Diagnostic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR)
  • Immunofluorescence Assays

7. Influenza Diagnostic Market Regional And Country Analysis

  • 7.1. Global Influenza Diagnostic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Influenza Diagnostic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Influenza Diagnostic Market

  • 8.1. Asia-Pacific Influenza Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Influenza Diagnostic Market

  • 9.1. China Influenza Diagnostic Market Overview
  • 9.2. China Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Influenza Diagnostic Market

  • 10.1. India Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Influenza Diagnostic Market

  • 11.1. Japan Influenza Diagnostic Market Overview
  • 11.2. Japan Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Influenza Diagnostic Market

  • 12.1. Australia Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Influenza Diagnostic Market

  • 13.1. Indonesia Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Influenza Diagnostic Market

  • 14.1. South Korea Influenza Diagnostic Market Overview
  • 14.2. South Korea Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Influenza Diagnostic Market

  • 15.1. Western Europe Influenza Diagnostic Market Overview
  • 15.2. Western Europe Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Influenza Diagnostic Market

  • 16.1. UK Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Influenza Diagnostic Market

  • 17.1. Germany Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Influenza Diagnostic Market

  • 18.1. France Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Influenza Diagnostic Market

  • 19.1. Italy Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Influenza Diagnostic Market

  • 20.1. Spain Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Influenza Diagnostic Market

  • 21.1. Eastern Europe Influenza Diagnostic Market Overview
  • 21.2. Eastern Europe Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Influenza Diagnostic Market

  • 22.1. Russia Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Influenza Diagnostic Market

  • 23.1. North America Influenza Diagnostic Market Overview
  • 23.2. North America Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Influenza Diagnostic Market

  • 24.1. USA Influenza Diagnostic Market Overview
  • 24.2. USA Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Influenza Diagnostic Market

  • 25.1. Canada Influenza Diagnostic Market Overview
  • 25.2. Canada Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Influenza Diagnostic Market

  • 26.1. South America Influenza Diagnostic Market Overview
  • 26.2. South America Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Influenza Diagnostic Market

  • 27.1. Brazil Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Influenza Diagnostic Market

  • 28.1. Middle East Influenza Diagnostic Market Overview
  • 28.2. Middle East Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Influenza Diagnostic Market

  • 29.1. Africa Influenza Diagnostic Market Overview
  • 29.2. Africa Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Influenza Diagnostic Market Competitive Landscape And Company Profiles

  • 30.1. Influenza Diagnostic Market Competitive Landscape
  • 30.2. Influenza Diagnostic Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Influenza Diagnostic Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson and Company
  • 31.2. DiaSorin SpA
  • 31.3. Luminex Corporation
  • 31.4. Meridian Bioscience Inc.
  • 31.5. GenMark Diagnostics Inc.
  • 31.6. SA Scientific Ltd.
  • 31.7. Sekisui Diagnostics LLC
  • 31.8. bioMerieux Inc.
  • 31.9. Danaher Corporation
  • 31.10. Siemens Healthineers AG
  • 31.11. Coris Bioconcept Sprl
  • 31.12. Mast Group
  • 31.13. Elitech Technology Inc.
  • 31.14. Analytik Jena AG
  • 31.15. altona Diagnostics GmbH

32. Global Influenza Diagnostic Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Influenza Diagnostic Market

34. Recent Developments In The Influenza Diagnostic Market

35. Influenza Diagnostic Market High Potential Countries, Segments and Strategies

  • 35.1 Influenza Diagnostic Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Influenza Diagnostic Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Influenza Diagnostic Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer